Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000437 · ClinicalTrials.gov registry record · Phase 4
Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)
A Phase 4 study, sponsored by The Scripps Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 60
- Enrollment target
NCT00000437: Completed Phase 4 study, sponsored by The Scripps Research Institute.
NCT00000437 is a Phase 4 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 60 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000437, a Phase 4 study, has completed, sponsored by The Scripps Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 60 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.
Interventions
- DRUG Naltrexone Tablet and Nicotine Patch
- DRUG Naltrexone Tablet and Placebo Patch
- DRUG Placebo Tablet and Nicotine Patch
- DRUG Placebo Tablet and Placebo Patch
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 1997-09-26 |
| Est. Completion | 2005-09-15 |
| Phase | Phase 4 |
What the finished NCT00000437 record still lists
NCT00000437 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (88% lower).
The record links to 0 conditions, and to 4 interventions - of which Naltrexone Tablet and Nicotine Patch is the first listed.
NCT00000437 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000437 about?
NCT00000437 is a clinical study titled "Tobacco Dependence in Alcoholism Treatment (Nicotine Patch/Naltrexone)". The purpose of this study is to determine the effectiveness of naltrexone (Revia) or matched placebo combined with nicotine patch (Nicotrol) or placebo patch using a 2x2 design in reducing drinking and smoking in patients with both nicotine and alcohol dependence.
What is the current status of trial NCT00000437?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 60 participants. The study started on 1997-09-26. Estimated completion is 2005-09-15.
What interventions are being tested in trial NCT00000437?
The interventions under investigation include: Naltrexone Tablet and Nicotine Patch (DRUG), Naltrexone Tablet and Placebo Patch (DRUG), Placebo Tablet and Nicotine Patch (DRUG), Placebo Tablet and Placebo Patch (DRUG).
Who is sponsoring clinical trial NCT00000437?
This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000437's enrollment target sits among peer trials
60 1125th of 2000 higher than 799 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00576069 · 60 participants
Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma
- NCT01297400 · 60 participants · Phase 2
Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns
- NCT01734122 · 60 participants
Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor
- NCT01804634 · 60 participants · Phase 2
Reduced Intensity Haploidentical BMT for High Risk Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI